Aarti Drugs Limited — Board Meeting, 06-05-2025: Outcome of Board Meeting

Aarti Drugs has announced a board meeting on the financial results for the quarter and half-year, reporting consolidated revenue of Rs. 2266.91 Cr and profit before tax of Rs. 64.18 Cr for the year. The company completed a buyback of 6.65 lakh shares at Rs. 900 each, trimming paid-up capital to Rs. 91.27 Cr. M/s GMVP & Associates LLP has been reappointed as Cost Auditor for FY2025-26. Subsidiaries now include Pinnacle Life Science, Aarti Speciality Chemicals, and the recently added Pinnacle Chile SpA, strengthening the group's global footprint.